Induction of Cellular and Humoral Immunity after Aerosol or Subcutaneous Administration of Edmonston-Zagreb Measles Vaccine as a Primary Dose to 12-Month-Old Children

Journal of Infectious Diseases

Volumn 189, Issue 2, 2004, Pages 254-257

  Wong Chew, Rosa María ^a,f   Islas Romero, Rocío ^c   García García, María De Lourdes ^c   Beeler, Judy A ^e   Audet, Susette ^e   Santos Preciado, Jose Ignacio ^a,b   Gans, Hayley ^d   Lew Yasukawa, Linda ^d   Maldonado, Yvonne A ^d   Arvin, Ann M ^d   Valdespino Gómez, José Luís ^c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTHRALGIA; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONFIDENCE INTERVAL; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG EFFECT; FEVER; GEOMETRY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NORMAL HUMAN; PRIORITY JOURNAL; RASH; RHINITIS; SEROCONVERSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

AEROSOLS; ANTIBODIES, VIRAL; FEMALE; HUMANS; INFANT; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; MEASLES VACCINE; T-LYMPHOCYTES; VACCINATION;

EID: 9144263546     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/380565     Document Type: Article

References (18)

1. World Health Organization. Global measles mortality reduction and regional elimination. Wkly Epidemiol Rec 2002; 77:49-56.
2. Cutts FT, Clements J, Bennett JV. Alternative routes of measles immunization: a review. Biologicals 1997; 25:323-38.
3. Fernández de Castro J, Kumate-Rodríguez J, Sepúlveda J, Ramírez-Isunza JM, Valdespino-Gómez JL. Measles vaccination by the aerosol method in Mexico [in Spanish]. Salud Publica Mex 1997; 39:53-60.
4. Fernández de Castro J, Valdespino Gomez JL, Díaz Ortega JL. Diploid cell measles vaccine. JAMA 1986; 256:714.
5. Dilraj A, Cutts F, Fernandez de Castro J, et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000; 355:798-803.
6. Sepulveda-Amor J, Valdespino-Gómez JL, García- García ML, et al. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children. Vaccine 2002; 20:2790-5.
7. Bennett J, Fenandez de Castro J, Valdespino-Gómez JL, et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 2002; 80:806-12.
8. Gans H, Arvin A, Galinus J, Logan L, DeHovitz R, Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 1998; 280:527-32.
9. Bautista-Lopez N, Ward BJ, Mills E, McCormick D, Martel N, Ratnam S. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine 2000; 18:1393-401.
10. Gans H, Yasukawa L, Rinki M, et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 2001; 184:817-26.
11. Gans HA, Maldonado Y, Yasukawa LL, et al. L-12, IFN-γ, and T cell proliferation to measles in immunized infants. J Immunol 1999; 162: 5569-75.
12. Pabst HF, Spady DW, Carson MM, Stelfox HT, Beeler JA, Krezolek MP. Kinetics of immunologic responses after primary MMR vaccination. Vaccine 1997; 15:10-4.
13. Ward BJ, Boulianne N, Ratnam S, Guiot MC, Couillard M, De Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis 1995; 172:1591-5.
14. Wong-Chew RM, Beeler JA, Audet S, Santos JI. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine. J Med Virol 2003; 70:276-80.
15. Albrecht P, Herrmann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 1981; 3:251-60.
16. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990; 162:1036-42.
17. Ruckdeschel JC, Graziano KD, Mardiney MR Jr. Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola). Cell Immunol 1975; 17:11-8.
18. Samb B, Aaby P, Whittle HC, et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 1995; 14:203-9.